Opaleye Management as of March 31, 2018
Portfolio Holdings for Opaleye Management
Opaleye Management holds 38 positions in its portfolio as reported in the March 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Axogen (AXGN) | 17.9 | $63M | 1.7M | 36.50 | |
| Blueprint Medicines (BPMC) | 15.7 | $55M | 600k | 91.70 | |
| Loxo Oncology | 5.9 | $21M | 179k | 115.37 | |
| Codexis (CDXS) | 5.3 | $19M | 1.7M | 11.00 | |
| Fibrogen | 4.8 | $17M | 360k | 46.20 | |
| Strongbridge Bioph shs usd | 4.0 | $14M | 1.6M | 8.85 | |
| Corium Intl | 3.5 | $12M | 1.1M | 11.47 | |
| Agios Pharmaceuticals (AGIO) | 3.0 | $11M | 130k | 81.78 | |
| Fennec Pharmaceuticals (FENC) | 3.0 | $11M | 873k | 12.10 | |
| Sangamo Biosciences (SGMO) | 2.9 | $10M | 535k | 19.00 | |
| Cymabay Therapeutics | 2.5 | $8.6M | 665k | 12.99 | |
| Amag Pharmaceuticals Inc note 2.500% 2/1 | 2.4 | $8.5M | 420k | 20.15 | |
| Miragen Therapeutics | 2.1 | $7.4M | 1.1M | 7.01 | |
| Deciphera Pharmaceuticals | 2.1 | $7.3M | 365k | 20.04 | |
| Ocular Therapeutix | 2.1 | $7.2M | 1.1M | 6.51 | |
| Xoma Corp Del (XOMA) | 1.9 | $6.5M | 320k | 20.23 | |
| Biofrontera | 1.9 | $6.5M | 391k | 16.52 | |
| Ardelyx (ARDX) | 1.6 | $5.7M | 1.1M | 5.05 | |
| Audentes Therapeutics | 1.6 | $5.7M | 190k | 30.05 | |
| Amarin Corporation | 1.5 | $5.3M | 1.7M | 3.01 | |
| Ablynx Nv | 1.4 | $4.9M | 90k | 54.56 | |
| Foamix Pharmaceuticals | 1.4 | $4.9M | 950k | 5.13 | |
| Viking Therapeutics (VKTX) | 1.4 | $4.8M | 1.1M | 4.37 | |
| Ultragenyx Pharmaceutical (RARE) | 1.2 | $4.1M | 80k | 50.99 | |
| Achillion Pharmaceuticals | 1.2 | $4.1M | 1.1M | 3.71 | |
| DepoMed | 1.1 | $4.0M | 600k | 6.59 | |
| Ptc Therapeutics I (PTCT) | 1.1 | $3.9M | 145k | 27.06 | |
| Tg Therapeutics (TGTX) | 1.1 | $3.9M | 274k | 14.20 | |
| Syndax Pharmaceuticals (SNDX) | 0.9 | $3.2M | 223k | 14.23 | |
| Chimerix (CMRX) | 0.9 | $3.1M | 600k | 5.20 | |
| Quanterix Ord (QTRX) | 0.7 | $2.6M | 150k | 17.04 | |
| Protalix BioTherapeutics | 0.5 | $1.8M | 3.3M | 0.54 | |
| Fortress Biotech | 0.4 | $1.4M | 315k | 4.55 | |
| Epizyme | 0.4 | $1.2M | 70k | 17.74 | |
| Syros Pharmaceuticals | 0.3 | $961k | 74k | 12.97 | |
| Zosano Pharma | 0.1 | $504k | 100k | 5.04 | |
| Quotient | 0.1 | $282k | 60k | 4.70 | |
| Biolinerx Ltd-spons | 0.1 | $215k | 250k | 0.86 |
